Literature DB >> 15932508

Respiratory syncytial virus and neutrophil activation.

E L Bataki1, G S Evans, M L Everard.   

Abstract

Respiratory syncytial virus infects almost all children by 2 years of age. Neutrophils are the predominant airway leucocytes in RSV bronchiolitis and they are activated in the presence of infection. However it is not clear whether RSV can directly signal to activate neutrophil cytotoxic function. To investigate this we have used a preparation of RSV washed using a new centrifugal diafiltration method to rapidly remove inflammatory molecules produced by the epithelial cells used to propagate the RSV stock. Human neutrophils were isolated from peripheral blood and activated with either the unwashed crude RSV preparations or the purified intact RSV. Neutrophils were also challenged with purified RSV G-glycoprotein. The effect of challenging human neutrophils with these preparations of intact RSV, or the RSV G-glycoprotein, was assessed by measuring the cell surface expression of CD11b and CD18b, the phagocytic oxidative burst, and intracellular release of calcium pools. Neutrophils challenged with the washed RSV exhibited significantly lower activation of surface marker expression (P < 0.001) and oxidative burst (P < 0.001) than those challenged with unwashed virus or with virus free supernatant. There was no increase in intracellular calcium release on exposure to the washed RSV. Purified G glycoprotein did not stimulate neutrophils, whilst the use of a blocking antibody to the F protein did not prevent unwashed RSV from activating cytotoxic responses. These results suggest that neutrophils have no innate signalling system that recognizes RSV but they are activated at sites of RSV infection as a result of the cytokines and inflammatory molecules released by virally infected cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932508      PMCID: PMC1809401          DOI: 10.1111/j.1365-2249.2005.02780.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  Fc gamma receptors of phagocytes.

Authors:  M de Haas; P J Vossebeld; A E von dem Borne; D Roos
Journal:  J Lab Clin Med       Date:  1995-10

2.  The stabilization and purification of respiratory syncytial virus using MgSO4.

Authors:  B F Fernie; J L Gerin
Journal:  Virology       Date:  1980-10-15       Impact factor: 3.616

3.  Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line.

Authors:  T L Noah; S Becker
Journal:  Am J Physiol       Date:  1993-11

4.  Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients.

Authors:  A Mbiguino; J Menezes
Journal:  J Virol Methods       Date:  1991 Feb-Mar       Impact factor: 2.014

5.  Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.

Authors:  S Becker; J Quay; J Soukup
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

6.  National surveillance for respiratory syncytial virus, United States, 1985-1990.

Authors:  S Gilchrist; T J Török; H E Gary; J P Alexander; L J Anderson
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

7.  Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis.

Authors:  A Jones; J M Qui; E Bataki; H Elphick; S Ritson; G S Evans; M L Everard
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

8.  Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

Authors:  M L Everard; A Swarbrick; M Wrightham; J McIntyre; C Dunkley; P D James; H F Sewell; A D Milner
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

9.  Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.

Authors:  R Arnold; B Humbert; H Werchau; H Gallati; W König
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

10.  Respiratory syncytial virus or influenza?

Authors:  D M Fleming; K W Cross
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  38 in total

Review 1.  The Interaction between Respiratory Pathogens and Mucus.

Authors:  Mark Zanin; Pradyumna Baviskar; Robert Webster; Richard Webby
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

2.  Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to Sendai virus infection.

Authors:  Antonina M Akk; Pamela M Simmons; Happy W Chan; Eugene Agapov; Michael J Holtzman; Mitchell H Grayson; Christine T N Pham
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

3.  Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Authors:  Jeremy V Camp; Ulas Bagci; Yong-Kyu Chu; Brendan Squier; Mostafa Fraig; Silvia M Uriarte; Haixun Guo; Daniel J Mollura; Colleen B Jonsson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection.

Authors:  Stanislaw J Gabryszewski; Ofir Bachar; Kimberly D Dyer; Caroline M Percopo; Kristin E Killoran; Joseph B Domachowske; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

5.  Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival.

Authors:  Marta L DeDiego; Jose L Nieto-Torres; Jose A Regla-Nava; Jose M Jimenez-Guardeño; Raul Fernandez-Delgado; Craig Fett; Carlos Castaño-Rodriguez; Stanley Perlman; Luis Enjuanes
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

6.  Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.

Authors:  A Jones; I Morton; L Hobson; G S Evans; M L Everard
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

7.  Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide.

Authors:  L Hobson; M L Everard
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

8.  Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.

Authors:  Kimberly D Dyer; Caroline M Percopo; Elizabeth R Fischer; Stanislaw J Gabryszewski; Helene F Rosenberg
Journal:  Blood       Date:  2009-08-03       Impact factor: 22.113

9.  Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

Authors:  Matthew R Murawski; Glennice N Bowen; Anna M Cerny; Larry J Anderson; Lia M Haynes; Ralph A Tripp; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

10.  Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4.

Authors:  Derek S Wheeler; Margaret A Chase; Albert P Senft; Sue E Poynter; Hector R Wong; Kristen Page
Journal:  Respir Res       Date:  2009-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.